| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4002354 | American Journal of Ophthalmology | 2014 | 9 Pages |
Abstract
Topical MMC and interferon alpha-2b are an effective treatment method for a wide range of noninvasive OSSNs. Topical therapy avoids the morbidity of excisional surgery with equivalent or reduced recurrence rates and should be considered as primary therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Jenna Besley, Juanita Pappalardo, Graham A. Lee, Lawrence W. Hirst, Stephen J. Vincent,